Best practices as recommended by WHO and United States Pharmacopoeia are being implemented for performing tests on therapeutic goods.
Recent Updates
- Decisions of 56th Meeting of Medical Device Board (Deficiency letter for Medical Devices Applications) March 27, 2023
- Stakeholders Comments are invited on the Draft Guidelines for Good Cold Chain Management Practices for Temperature-Sensitive Drug Products March 27, 2023
- Decisions of 55th Meeting of Medical Device Board (Deficiency letter for Medical Devices Applications) March 20, 2023
- Decisions of 54th Meeting of Medical Device Board (Deficiency letter for Medical Devices Applications) March 20, 2023
- Tender Notice – Security Service March 16, 2023
- Important Notice to Pharmaceutical / Biological Manufacturers and Importers March 13, 2023
- Recall Alert: Drug Product; Opth-Carb Sterile Intraocular Solution (Batch#OP154) by M/s Opth Pharma (Pvt) Ltd., Karachi. March 13, 2023
- Conduct of Open E-Kachehri March 10, 2023
- Med Safety App Updates; Mobile Application for Reporting of Adverse Drug Reaction is Updated and Improved March 9, 2023
- Safety Alert: WHO Global Alert on Tetracycline Hydrochloride Ophthalmic Ointment USP 1% March 6, 2023
Leadership
- Dr. M. Fakhr-e-Alam
Secretary, Ministry of NHSR&C - Mr. Asim Rauf
Chief Executive Officer, DRAP

E-Services
With the effective use of Information Technology, we have implemented a number of online services and continually working for more. Click Here to Register an account for following online services. Online Challan & Fee Submission fee.dra.gov.pk Commercial Import & Export

Guidelines
Regulatory compliance is essential and indispensable in order to assure the safety, quality and efficacy of therapeutic goods. Guidance documents published by the Authority are meant to explain the current interpretation or policy for better understanding of the industry and

Quality Control Labs
For ensuring quality therapeutic goods, a network of quality control laboratories has been established. DRAP approved products and suspect therapeutic goods are tested for their quality in accordance with best international practices. To keep the citizens safe from substandard and

Therapeutic Products Recalls
The Recalled Product Index provides access to consumers, healthcare professionals, industry, hospitals and sale outlets related to the information of recalled action taken for defective therapeutic goods. The following section provides an index of recalled actions in which a public

Health Professional Alerts
DRAP’s issues safety updates and alerts related to the therapeutic goods in order to ensure that healthcare professionals and other stakeholders have timely access to the relevant information on safety, quality and efficacy issues or benefit/risk evaluations of the drugs,

Open Consultations
Public consultation enables organizations to consider views and ideas from the citizens and relevant stakeholders during the development of new regulatory mechanisms, either through enactment of new rules and policies or changes to existing one, or by the development and
Implementation of Online Import & Export System
We are delighted to announce that DRAP has taken one more facilitation step for the convenience of Importers and Exporters.
Do you know?
DRAP ensures that every drug, medical device or cosmetic, alternative medicine and health product must have a certain standard of quality and is safe and effective for your use. See in links below how it is done and what to do in case you find a suspect therapeutic good.